{
    "clinical_study": {
        "@rank": "40034", 
        "arm_group": {
            "arm_group_label": "STX209", 
            "arm_group_type": "Experimental", 
            "description": "Active treatment with STX209"
        }, 
        "brief_summary": {
            "textblock": "This is an open-label extension protocol that will provide necessary data on the safety,\n      tolerability, pharmacokinetics and efficacy of STX209 among subjects with ASD."
        }, 
        "brief_title": "Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Autism Spectrum Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is an open label extension study enrolling by invitation only to those subjects that\n      have completed Seaside protocols 209AS208 and 22007.\n\n      Protocol 209AS208, \"A Randomized,Double-Blind, Placebo-Controlled, Study of the Efficacy,\n      Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social\n      Withdrawal in Subjects with Autism Spectrum Disorders.\"\n\n      Protocol 22007, \"An Open Label Extension Study to Evaluate the Safety, Tolerability and\n      Pharmacokinetics of STX209 in Subjects with Autism Spectrum Disorder.\"\n\n      This open-label extension will provide data on the following:\n\n        1. Evaluate the safety and tolerability of long term use of STX209 (Arbaclofen)\n\n        2. Provide supporting pharmacokinetic analyses\n\n        3. Assess long term efficacy on social behaviors in subjects with ASD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject completed study 22007 or 209AS208, and showed he can adequately follow the\n             protocol, and with adequate medical justification to enter this study.\n\n          -  Parent or other legally-authorized representative or caregiver is willing and able to\n             perform all protocol-specified functions.\n\n          -  Treatment with no more than 2 psychoactive medications\n\n          -  Subjects with a history of seizure disorder must be adequately well-controlled, as\n             specified in the study protocol\n\n          -  For female subjects, negative pregnancy test\n\n        Exclusion Criteria:\n\n          -  Comorbid conditions that might interfere with the conduct of the study or confound\n             the interpretation of the study data, or endanger the subject.\n\n          -  Current use of illicit drugs or alcohol abuse.\n\n          -  Subjects with a serious adverse event or other adverse event in study 22007 or\n             209AS208 that was related to STX209, and that endangers the subject, in the opinion\n             of the investigator\n\n          -  Current use of another investigational drug, or of vigabatrin, tiagabine, or riluzole"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "165", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706523", 
            "org_study_id": "209AS209"
        }, 
        "intervention": {
            "arm_group_label": "STX209", 
            "description": "Long-term, daily, orally-administered STX209", 
            "intervention_name": "STX209 (arbaclofen)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Autism Spectrum Disorders", 
            "Autism", 
            "Asperger", 
            "Pervasive Developmental Disorder - Not otherwise specified"
        ], 
        "lastchanged_date": "July 30, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85006"
                    }, 
                    "name": "Southwest Autism Research & Resource Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90024"
                    }, 
                    "name": "University of California-Los Angeles Neuropsychiatric Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "UCDavis M.I.N.D Insitute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33126"
                    }, 
                    "name": "Pharmax Research Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange City", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32763"
                    }, 
                    "name": "Lake Mary Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smyrna", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30080"
                    }, 
                    "name": "Institute for Behavioral Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60608"
                    }, 
                    "name": "Institute for Juvenile Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Riley Hospital for Children"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }, 
                    "name": "Kennedy Krieger Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Boston Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01605"
                    }, 
                    "name": "University of Massachusetts"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65211"
                    }, 
                    "name": "University of Missouri, Thompson Research Center for Autism & Neurodevelopmental Disorders"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Seaver Autism Center, Mount Sinai Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Staten Island", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10314"
                    }, 
                    "name": "NYS Institute for Basic Research in Developmental Disabilities"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27514"
                    }, 
                    "name": "UNC Chapel Hill Department of Psychiatry"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44308"
                    }, 
                    "name": "Akron Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73116"
                    }, 
                    "name": "Cutting Edge Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Summit Research Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Media", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19063"
                    }, 
                    "name": "Suburban Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Children's Hospital of Philadelphia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38103"
                    }, 
                    "name": "University of Tennessee Medical Group, LeBonheur Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "Vanderbilt Kennedy Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77090"
                    }, 
                    "name": "Red Oaks Psychiatry Associates, P.A."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78258"
                    }, 
                    "name": "Road Runner Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98101"
                    }, 
                    "name": "Seattle Children's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-Label Extension Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of STX209 (Arbaclofen) in Subjects With Autism Spectrum Disorders", 
        "overall_official": {
            "affiliation": "Seaside Therapeutics, Inc.", 
            "last_name": "Paul Wang, M.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Spontaneously-reported adverse events, physical examination, and clinical laboratory assessments", 
            "measure": "Safety and tolerability of STX209", 
            "safety_issue": "Yes", 
            "time_frame": "100 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706523"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Open-label assessment of change from baseline on the ABC", 
            "measure": "Aberrant Behavior Checklist", 
            "safety_issue": "Yes", 
            "time_frame": "100 weeks"
        }, 
        "source": "Seaside Therapeutics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seaside Therapeutics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}